LeadIQ logo
Learn more at LeadIQ.com

Insights

Key Partnership with Beta Bionics Xeris Pharmaceuticals has partnered with Beta Bionics to develop a dual-hormone pump for diabetes. This collaboration presents an opportunity for sales teams to explore joint offerings that cater to diabetes management solutions, potentially expanding market reach and boosting sales.

Funding and Financial Growth With recent financing of $200M and revenue ranging between $50M to $100M, Xeris Pharmaceuticals displays financial stability and growth potential. Sales development representatives can capitalize on this financial strength to negotiate larger deals, secure long-term partnerships, and drive revenue growth for the company.

Expanded Product Development Xeris Pharmaceuticals is actively developing advanced products such as a glucagon product and innovative injection solutions. Sales professionals can leverage these upcoming product releases to engage with existing and potential clients, showcasing the company's commitment to innovation and expanding product portfolio to drive sales.

CEO Succession Plan Xeris Pharmaceuticals announced a CEO succession plan, marking the retirement of Paul Edick. This leadership transition presents an opportune time for sales representatives to connect with the new CEO, establish fresh relationships, and align sales strategies with the company's evolving vision, potentially opening doors to new business opportunities.

Market Expansion through Partnerships Through strategic collaborations with companies like Regeneron, Xeris Pharmaceuticals is venturing into new markets and diversifying its product offerings. Sales development representatives can use these partnerships to access new customer segments, explore cross-selling opportunities, and enhance market penetration, driving sales growth for the company.

Similar companies to Xeris Pharmaceuticals, Inc.

Xeris Pharmaceuticals, Inc. Tech Stack

Xeris Pharmaceuticals, Inc. uses 8 technology products and services including WordPress, React, Open Graph, and more. Explore Xeris Pharmaceuticals, Inc.'s tech stack below.

  • WordPress
    Content Management System
  • React
    Javascript Frameworks
  • Open Graph
    Miscellaneous
  • Akamai Bot Manager
    Security
  • Google Tag Manager
    Tag Management
  • FedEx
    Transportation And Fleet Management
  • IIS
    Web Servers
  • Linkedin
    Widgets

Media & News

Xeris Pharmaceuticals, Inc.'s Email Address Formats

Xeris Pharmaceuticals, Inc. uses at least 1 format(s):
Xeris Pharmaceuticals, Inc. Email FormatsExamplePercentage
FLast@xerispharma.comJDoe@xerispharma.com
96%
Last@xerispharma.comDoe@xerispharma.com
2%
FMiddleLast@xerispharma.comJMichaelDoe@xerispharma.com
1%
FiLast@xerispharma.comJoDoe@xerispharma.com
1%

Frequently Asked Questions

Where is Xeris Pharmaceuticals, Inc.'s headquarters located?

Minus sign iconPlus sign icon
Xeris Pharmaceuticals, Inc.'s main headquarters is located at 180 N. Lasalle Chicago, IL 60601 US. The company has employees across 5 continents, including North AmericaEuropeOceania.

What is Xeris Pharmaceuticals, Inc.'s phone number?

Minus sign iconPlus sign icon
You can contact Xeris Pharmaceuticals, Inc.'s main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Xeris Pharmaceuticals, Inc.'s stock symbol?

Minus sign iconPlus sign icon
Xeris Pharmaceuticals, Inc. is a publicly traded company; the company's stock symbol is XERS.

What is Xeris Pharmaceuticals, Inc.'s official website and social media links?

Minus sign iconPlus sign icon
Xeris Pharmaceuticals, Inc.'s official website is xerispharma.com and has social profiles on LinkedIn.

How much revenue does Xeris Pharmaceuticals, Inc. generate?

Minus sign iconPlus sign icon
As of September 2024, Xeris Pharmaceuticals, Inc.'s annual revenue reached $75M.

What is Xeris Pharmaceuticals, Inc.'s NAICS code?

Minus sign iconPlus sign icon
Xeris Pharmaceuticals, Inc.'s NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does Xeris Pharmaceuticals, Inc. have currently?

Minus sign iconPlus sign icon
As of September 2024, Xeris Pharmaceuticals, Inc. has approximately 407 employees across 5 continents, including North AmericaEuropeOceania. Key team members include Vice President Global Regulatory Affairs & Operations: M. Y.Vice President Quality: L. O.Vice President Of Sales: M. B. M.. Explore Xeris Pharmaceuticals, Inc.'s employee directory with LeadIQ.

What industry does Xeris Pharmaceuticals, Inc. belong to?

Minus sign iconPlus sign icon
Xeris Pharmaceuticals, Inc. operates in the Pharmaceutical Manufacturing industry.

What technology does Xeris Pharmaceuticals, Inc. use?

Minus sign iconPlus sign icon
Xeris Pharmaceuticals, Inc.'s tech stack includes WordPressReactOpen GraphAkamai Bot ManagerGoogle Tag ManagerFedExIISLinkedin.

What is Xeris Pharmaceuticals, Inc.'s email format?

Minus sign iconPlus sign icon
Xeris Pharmaceuticals, Inc.'s email format typically follows the pattern of . Find more Xeris Pharmaceuticals, Inc. email formats with LeadIQ.

How much funding has Xeris Pharmaceuticals, Inc. raised to date?

Minus sign iconPlus sign icon
As of September 2024, Xeris Pharmaceuticals, Inc. has raised $200M in funding. The last funding round occurred on Mar 06, 2024 for $200M.

When was Xeris Pharmaceuticals, Inc. founded?

Minus sign iconPlus sign icon
Xeris Pharmaceuticals, Inc. was founded in 2005.
Xeris Pharmaceuticals, Inc.

Xeris Pharmaceuticals, Inc.

Pharmaceutical ManufacturingIllinois, United States201-500 Employees

We're a growth-oriented biopharmaceutical company improving patient lives by developing and commercializing advanced products across a range of therapies.

Section iconCompany Overview

Headquarters
180 N. Lasalle Chicago, IL 60601 US
Phone number
Stock Symbol
XERS
NAICS Code
3254 - Pharmaceutical and Medicine Manufacturing
Founded
2005
Employees
201-500

Section iconFunding & Financials

  • $200M

    Xeris Pharmaceuticals, Inc. has raised a total of $200M of funding over 14 rounds. Their latest funding round was raised on Mar 06, 2024 in the amount of $200M.

  • $50M$100M

    Xeris Pharmaceuticals, Inc.'s revenue is in the range of $50M$100M

Section iconFunding & Financials

  • $200M

    Xeris Pharmaceuticals, Inc. has raised a total of $200M of funding over 14 rounds. Their latest funding round was raised on Mar 06, 2024 in the amount of $200M.

  • $50M$100M

    Xeris Pharmaceuticals, Inc.'s revenue is in the range of $50M$100M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.